Epstein–Barr virus-associated T-and NK-cell lymphoproliferative diseases: an update and diagnostic approach
Summary Epstein–Barr virus (EBV)-positive T-cell and natural killer (NK)-cell
lymphoproliferative diseases (EBV-TNKLPD) are a group of uncommon disorders …
lymphoproliferative diseases (EBV-TNKLPD) are a group of uncommon disorders …
Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases
WY Kim, IA Montes-Mojarro, F Fend… - Frontiers in …, 2019 - frontiersin.org
EBV-associated T and NK-cell lymphoproliferative diseases (EBV-T/NK LPDs) are
characterized by the transformation and proliferation of EBV-infected T or NK cells. The 2016 …
characterized by the transformation and proliferation of EBV-infected T or NK cells. The 2016 …
Epstein-Barr virus (EBV)–associated lymphoid proliferations, a 2018 update
SA Rezk, X Zhao, LM Weiss - Human pathology, 2018 - Elsevier
Epstein-Barr virus (EBV) has been linked to many human neoplasms including
hematopoietic, epithelial, and mesenchymal tumors. Since our original review of EBV …
hematopoietic, epithelial, and mesenchymal tumors. Since our original review of EBV …
Aggressive NK cell leukemia: current state of the art
Simple Summary Aggressive natural killer cell leukemia (ANKL) is a rare, lethal disease that
presents many diagnostic and therapeutic challenges. Recent studies have shed new light …
presents many diagnostic and therapeutic challenges. Recent studies have shed new light …
EBV-negative aggressive NK-cell leukemia/lymphoma: clinical, pathologic, and genetic features
A Nicolae, KA Ganapathi, THT Pham, L Xi… - The American journal …, 2017 - journals.lww.com
Aggressive natural killer cell leukemia (ANKL) is a systemic NK-cell neoplasm, almost
always associated with Epstein-Barr virus (EBV). Rare cases of EBV-negative ANKL have …
always associated with Epstein-Barr virus (EBV). Rare cases of EBV-negative ANKL have …
The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms)
RR Maronpot, A Nyska, JE Foreman… - Critical Reviews in …, 2016 - Taylor & Francis
Abstract The Fischer 344 (F344) rat was used by the National Toxicology Program (NTP) for
over 5 decades for toxicity and carcinogenicity studies. However, in 2006, the NTP decided …
over 5 decades for toxicity and carcinogenicity studies. However, in 2006, the NTP decided …
[HTML][HTML] EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution
J Gao, A Behdad, P Ji, KL Wolniak, O Frankfurt… - Modern Pathology, 2017 - Elsevier
Aggressive natural killer (NK)-cell leukemia/lymphoma is a systemic NK-cell neoplasm that
preferentially affects Asians with a fulminant clinical course and is almost always associated …
preferentially affects Asians with a fulminant clinical course and is almost always associated …
Clinicopathologic characterization of aggressive natural killer cell leukemia involving different tissue sites
LM Gao, S Zhao, WP Liu, WY Zhang… - The American Journal …, 2016 - journals.lww.com
Aggressive natural killer cell leukemia (ANKL) is a rare disease with an extremely
aggressive clinical course. The etiology of ANKL is unclear with few genetic/epigenetic …
aggressive clinical course. The etiology of ANKL is unclear with few genetic/epigenetic …
[图书][B] Atlas of differential diagnosis in neoplastic hematopathology
W Gorczyca - 2021 - taylorfrancis.com
This atlas presents not only the differential diagnosis but also the detailed morphologic,
immunophenotypic, and especially genetic characteristics of the majority of hematolymphoid …
immunophenotypic, and especially genetic characteristics of the majority of hematolymphoid …
Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective …
Y Li, J Wei, X Mao, Q Gao, L Liu, P Cheng, L Liu… - PLoS …, 2016 - journals.plos.org
Aggressive natural killer cell leukemia (ANKL) is a fatal hematological neoplasm
characterized by a fulminating clinical course and extremely high mortality. Current …
characterized by a fulminating clinical course and extremely high mortality. Current …